Rifater is a combination medication used in the treatment of tuberculosis (TB). It contains three active ingredients: rifampin, isoniazid, and pyrazinamide, which work together to kill or stop the growth of the bacteria that cause TB. By combining these drugs, Rifater simplifies the treatment regimen, potentially improving patient compliance with the therapy. It is typically used during the initial phase of TB treatment, which is crucial for preventing the development of drug resistance. Like all medications used to treat TB, it is important that Rifater be taken exactly as prescribed by a healthcare professional to ensure the effectiveness of the treatment and to minimize the risk of side effects.